Fact CheckerSign in

NCT04536272CompletedPhase 3

Reduced Anticoagulation Targets in ECLS (RATE)

Source: ClinicalTrials.gov · Last updated 2 May 2025

Brief summary (registry, in English)

The objective of the RATE-trial is to study if reduced anticoagulation targets during ECLS diminish bleeding complications without an increase in thromboembolic complications or a negative impact on outcome.

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
330 (actual)
First submitted
24 Aug 2020
Start date
1 Oct 2020
Primary completion date
7 Mar 2025
Lead sponsor
University Medical Center Groningen
NCT number
NCT04536272
EudraCT number
2019-004125-24

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 330
  • From 1 Oct 2020 to the primary completion date, 7 Mar 2025
  • 8 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of heparin induced thrombocytopenia

Other

  • Patients in whom the ECMO is only used to bridge a procedure
  • Vital indication for robust anticoagulation (e.g. mechanic valve, pulmonary embolism)

Who the study is looking for

  • ECMO treatment during the study period in one of the participating centers
  • Age above 18 years
  • Written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Amsterdam UMC, location AMC
Coordinator of this site? Confirm its status
AmsterdamNetherlandsUnknown status
OLVG location East
Coordinator of this site? Confirm its status
AmsterdamNetherlandsUnknown status
University Medical Center Groningen
Coordinator of this site? Confirm its status
GroningenNetherlandsUnknown status
Leids Universitair Medisch Centrum
Coordinator of this site? Confirm its status
LeidenNetherlandsUnknown status
Maastricht Universitair Medisch Centrum
Coordinator of this site? Confirm its status
MaastrichtNetherlandsUnknown status
Radboud UMC
Coordinator of this site? Confirm its status
NijmegenNetherlandsUnknown status
Erasmus MC
Coordinator of this site? Confirm its status
RotterdamNetherlandsUnknown status
Isala Clinics
Coordinator of this site? Confirm its status
ZwolleNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.